Study Shows High Concentration of Insurance Companies Nationwide: A Threat to Patients and Communities

The vast majority of health insurance markets in the U.S. are highly concentrated.  This is the key finding in the 2013 edition of the American Medical Association’s annual report Competition in Health Insurance: A Comprehensive Study of U.S. Markets.  The report also suggests, based on a growing body of evidence, that insurers are exercising their market power to cause competitive harm to patients and their providers of care. 

In this 12th edition of the study, the AMA assessed the level of insurer concentration in 386 metropolitan areas, covering all 50 states across the country and the District of Columbia.  As such, Competition in Health Insurance is the largest, most complete picture of competition in the commercial health insurance market.  Based on 2011 data, the 2013 report confirms a trend outlined by the AMA in years past: insurers have dominance in a majority of markets, and it suggests that insurers are using it to harm patients and their providers through anticompetitive behavior.

The numbers are staggering:

  • 71% of metropolitan areas studied are rated “highly concentrated”
  • 89% of metropolitan areas have one insurer with 30% or more of the market share
  • In 15 states a single insurance company controls 50% or more of the market share
  • And perhaps most significant: in 45 states, one or two insurance companies control 50% or more of the market share.

Insurance companies’ growing market power enhances their ability to raise premiums and command terms and conditions from both patients and their providers.  This power was demonstrated during 2000 – 2008 when many health insurance companies significantly increased the amount of premium dollars they kept for profit and administrative expenses.  At the same time, they spent less of those dollars on patients’ medical care and quality improvement—as shown by insurance industry data on medical loss ratio (MLR) in a 2013 report from the Center for Regulatory Effectiveness. Although this practice was restricted by the Patient Protection and Affordable Care Act, insurers continue to use their market power to achieve a win-win for insurers, while patients and their providers lose out.

The more leverage insurers have, the more difficult it is for patients, hospitals and other care providers to negotiate terms of care, which in turn threatens patient access to care.  Hospitals need a level playing field from which to negotiate with insurance companies so they can protect patient access, keep their doors open and continue to provide quality care 24/7.

Despite every insurer’s claim to the contrary, their leverage and market power across the United States is strong, and growing stronger each year.  Insurers continue to grow their influence and profit margins in cities and states across the country to drive up premium prices and control negotiations with consumers and care givers.  As insurance companies participate in these tactics, the financial strain felt by patients worsens and the threat to patients and communities increases.

And though insurers are wont to claim hospital realignment is increasing hospitals’ market power and driving competition out of the market, a new study in 2014 shows that not to be the case.  Hospital realignment is shown to bring a wealth of benefits to patients and local communities and does not impede market competition, according to the report by FTI’s Center for Healthcare Economics and Policy.  The report—which is the most comprehensive of its kind, amassing the most current data—highlights the insurers’ agenda: unfounded claims to distract from a policy of “do as I say, not as I do.”

The 2013 AMA study proves once again insurers are pursuing greater anticompetitive actions while reaping profits at the sake of consumers.  As market dominance increases, so too do the premiums and cost-sharing responsibilities for patients.  The proof is in the numbers, and one thing is clear: the only group benefitting are insurance companies.

Insurer Concentration and Market Power

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>